Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

DERA Inhibitors

Chemical inhibitors of DERA can exert their inhibitory effects through various biochemical mechanisms, primarily focusing on the enzyme's substrate specificity and catalytic activity. Pentostatin is an inhibitor that targets adenosine deaminase, an enzyme closely linked to the function of DERA. By inhibiting adenosine deaminase, this chemical causes an accumulation of deoxyadenosine (dAdo), which is a substrate for DERA. The elevated levels of dAdo lead to feedback inhibition of DERA, as the enzyme becomes saturated with its substrate, decreasing its overall activity. Similarly, Erythro-9-(2-hydroxy-3-nonyl)adenine functions as an adenosine deaminase inhibitor, thereby increasing dAdo concentrations which then compete with the natural substrate of DERA, leading to inhibition through substrate competition.

Further, analogs of adenosine such as Vidarabine, Cladribine, Fludarabine, and Nelarabine are phosphorylated to their active forms within the cell and mimic the natural substrate of DERA. These active triphosphate forms can bind to the active site of DERA, competitively inhibiting the enzyme by preventing the binding of the actual substrate. Clofarabine, also an analog, is metabolized into its triphosphate form, which competes with deoxyadenosine, DERA's natural substrate, and inhibits the enzyme's activity. Tubercidin and 8-Azaadenosine share a similar mechanism by acting as adenosine analogs that can be incorporated into DNA, where they interfere with DERA by resembling its natural substrate and thus inhibiting its function. Sangivamycin, yet another purine nucleoside analog, inhibits enzymes like DERA by mimicking the natural substrate, leading to the enzyme's inhibition. Lastly, 2'-Deoxyadenosine 5'-monophosphate, a direct product of DERA's catalytic action, can result in product inhibition, which is a typical form of enzyme inhibition where the accumulation of the product directly inhibits the enzyme's activity. This form of inhibition ensures that DERA activity is tightly regulated and can be controlled by the concentration of its own reaction product.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Pentostatin

53910-25-1sc-204177
sc-204177A
10 mg
50 mg
$172.00
$702.00
5
(1)

Similar to deoxycoformycin, pentostatin inhibits adenosine deaminase, causing an accumulation of dAdo and thereby inhibiting DERA activity.

Vidarabine

5536-17-4sc-205881
sc-205881A
100 mg
500 mg
$52.00
$137.00
1
(1)

As an adenosine analog, vidarabine can be phosphorylated to its active triphosphate form, which can competitively inhibit DERA.

2-Chloro-2′-deoxyadenosine

4291-63-8sc-202399
10 mg
$144.00
1
(0)

Another adenosine deaminase-resistant analog, cladribine triphosphate can compete with the natural substrate of DERA, leading to inhibition.

Fludarabine

21679-14-1sc-204755
sc-204755A
5 mg
25 mg
$57.00
$200.00
15
(1)

Phosphorylated fludarabine acts as a competitive inhibitor for DERA by mimicking its natural substrate.

Clofarabine

123318-82-1sc-278864
sc-278864A
10 mg
50 mg
$185.00
$781.00
(0)

Clofarabine triphosphate competes with deoxyadenosine, the natural substrate of DERA, thus inhibiting its enzymatic activity.

Tubercidin

69-33-0sc-258322
sc-258322A
sc-258322B
10 mg
50 mg
250 mg
$184.00
$663.00
$1958.00
(1)

As an adenosine analog, tubercidin can be incorporated into DNA and interfere with enzymes like DERA that act on nucleoside substrates.

Sangivamycin

18417-89-5sc-204261
sc-204261A
sc-204261B
sc-204261C
sc-204261D
sc-204261E
1 mg
10 mg
25 mg
50 mg
100 mg
250 mg
$326.00
$1322.00
$2560.00
$5110.00
$9700.00
$19900.00
(1)

A purine nucleoside analog that acts as an inhibitor for enzymes like DERA by resembling the natural substrate.